1.14 USD
▲+0.05+9.62%
盘后 1.05 +0.96%
2026-08-03
市值
$10.38M
市盈率
—
EPS
-1.86
股息率
—
52 周区间
0.99 – 5.07
成交量
162.26K
Beta
0.88
目标价
4.00
52W 低 0.9952W 高 5.07
价格走势
公司简介
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as C...